Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial

Silvia Dellapasqua; Kathryn P. Gray; Elisabetta Munzone; Daniela Rubino; Lorenzo Gianni; Harriet Johansson; Giuseppe Viale; Karin Ribi; Jürg Bernhard; Roswitha Kammler; Rudolf Maibach; Manuela Rabaglio-Poretti; Barbara Ruepp; Angelo Di Leo; Alan S. Coates; Richard D. Gelber; Meredith M. Regan; Aron Goldhirsch; Marco Colleoni

doi:10.1200/JCO.18.00296

Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial

Silvia Dellapasqua
, Kathryn P. Gray
, Elisabetta Munzone
, Daniela Rubino
, Lorenzo Gianni
, Harriet Johansson
, Giuseppe Viale
, Karin Ribi
, Jürg Bernhard
, Roswitha Kammler
, Rudolf Maibach
, Manuela Rabaglio-Poretti
, Barbara Ruepp
, Angelo Di Leo
, Alan S. Coates
, Richard D. Gelber
, Meredith M. Regan
, Aron Goldhirsch
, Marco Colleoni

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	386-395
Fachzeitschrift	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Jahrgang	37
Ausgabenummer	5
DOIs	https://doi.org/10.1200/JCO.18.00296
Publikationsstatus	Veröffentlicht - 10 Feb. 2019
Extern publiziert	Ja

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Zugriff auf Dokument

10.1200/JCO.18.00296

https://ascopubs.org/doi/10.1200/JCO.18.00296

Dieses zitieren

Dellapasqua, S., Gray, K. P., Munzone, E., Rubino, D., Gianni, L., Johansson, H., Viale, G., Ribi, K., Bernhard, J., Kammler, R., Maibach, R., Rabaglio-Poretti, M., Ruepp, B., Di Leo, A., Coates, A. S., Gelber, R. D., Regan, M. M., Goldhirsch, A., & Colleoni, M. (2019). Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 37(5), 386-395. https://doi.org/10.1200/JCO.18.00296

Dellapasqua, Silvia ; Gray, Kathryn P. ; Munzone, Elisabetta et al. / Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial. in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 ; Jahrgang 37, Nr. 5. S. 386-395.

@article{d0b3b52f89bc48adb199ca67230f883d,

title = "Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial",

author = "Silvia Dellapasqua and Gray, \{Kathryn P.\} and Elisabetta Munzone and Daniela Rubino and Lorenzo Gianni and Harriet Johansson and Giuseppe Viale and Karin Ribi and J{\"u}rg Bernhard and Roswitha Kammler and Rudolf Maibach and Manuela Rabaglio-Poretti and Barbara Ruepp and \{Di Leo\}, Angelo and Coates, \{Alan S.\} and Gelber, \{Richard D.\} and Regan, \{Meredith M.\} and Aron Goldhirsch and Marco Colleoni",

year = "2019",

month = feb,

day = "10",

doi = "10.1200/JCO.18.00296",

language = "English",

volume = "37",

pages = "386--395",

journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

Dellapasqua, S, Gray, KP, Munzone, E, Rubino, D, Gianni, L, Johansson, H, Viale, G, Ribi, K, Bernhard, J, Kammler, R, Maibach, R, Rabaglio-Poretti, M, Ruepp, B, Di Leo, A, Coates, AS, Gelber, RD, Regan, MM, Goldhirsch, A & Colleoni, M 2019, 'Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Jg. 37, Nr. 5, S. 386-395. https://doi.org/10.1200/JCO.18.00296

Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial. / Dellapasqua, Silvia; Gray, Kathryn P.; Munzone, Elisabetta et al.
in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Jahrgang 37, Nr. 5, 10.02.2019, S. 386-395.

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

TY - JOUR

T1 - Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial

AU - Dellapasqua, Silvia

AU - Gray, Kathryn P.

AU - Munzone, Elisabetta

AU - Rubino, Daniela

AU - Gianni, Lorenzo

AU - Johansson, Harriet

AU - Viale, Giuseppe

AU - Ribi, Karin

AU - Bernhard, Jürg

AU - Kammler, Roswitha

AU - Maibach, Rudolf

AU - Rabaglio-Poretti, Manuela

AU - Ruepp, Barbara

AU - Di Leo, Angelo

AU - Coates, Alan S.

AU - Gelber, Richard D.

AU - Regan, Meredith M.

AU - Goldhirsch, Aron

AU - Colleoni, Marco

PY - 2019/2/10

Y1 - 2019/2/10

U2 - 10.1200/JCO.18.00296

DO - 10.1200/JCO.18.00296

M3 - Article

SN - 0732-183X

VL - 37

SP - 386

EP - 395

JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

IS - 5

ER -

Dellapasqua S, Gray KP, Munzone E, Rubino D, Gianni L, Johansson H et al. Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Feb. 10;37(5):386-395. doi: 10.1200/JCO.18.00296